Fastcompany iconFastcompanySep 4, 2026 ~1 min source read

The Pentagon’s laser weapon era is finally here

Army has awarded defense contractor AV a $464.8 million contract for the production of high-energy laser weapons under the Enduring High Energy Laser (E-HEL) program, the service announced —the U.S. military's first formal directed energy program of record and a major milestone for laser weapons after decades of research and development.

The Pentagon’s laser weapon era is finally here

Share this story

Send the public story page.

Useful takeaways from this story.

Army has awarded defense contractor AV a $464.8 million contract for the production of high-energy laser weapons under the Enduring High Energy Laser (E-HEL) program, the service announced —the U.S.

military's first formal directed energy program of record and a major milestone for laser weapons after decades of research and development.

Agreement (OTA) will see AV equip the Army with 26 30-kilowatt LOCUST X3 laser weapons over the next five years to counter the urgent threat of low-cost weaponized drones, the company said in a statement on...

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

Army has awarded defense contractor AV a $464.8 million contract for the production of high-energy laser weapons under the Enduring High Energy Laser (E-HEL) program, the service announced —the U.S. military's first formal directed energy program of record and a major milestone for laser weapons after decades of research and development. Agreement (OTA) will see AV equip the Army with 26 30-kilowatt LOCUST X3 laser weapons over the next five years to counter the urgent threat of low-cost weaponized drones, the company said in a statement on September 2.

How it works

  • Formally unveiled in March and designed specifically for the E-HEL program, the X3 is the latest iteration of the company's tried-and-true LOCUST Laser...

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app